| Issue |
Section |
Title |
File |
| No 5 (2009) |
Articles |
Contraception in women with autoimmune pathology |
|
| No 1 (2011) |
Articles |
THE CLINICAL VALUE OF GONADOTROPIC HORMONE AUTOANTIBODIES IN FEMALE REPRODUCTIVE DYSFUNCTION |
|
| No 3 (2011) |
Articles |
IGG SUBCLASSES DISTRIBUTION AND PATHOGENETIC ACTIVITY OF AUTOANTIBODIES TO HUMAN CHORIONIC GONADOTROPIN N WOMEN WITH A HISTORY OF REPRODUCTIVE FAILURE |
|
| No 5 (2011) |
Articles |
AUTOANTIBODIES TO GONADOTROPIC HORMONES AND TESTOSTERONE IN MALE INFERTILITY |
|
| No 2 (2012) |
Articles |
ANTIBODIES TO REPRODUCTIVE HORMONES AS A POSSIBLE RISK FACTOR FOR POOR OUTCOME OF IN VITRO FERTILIZATION CYCLES |
|
| No 9 (2014) |
Articles |
Poor ovarian response in assisted reproductive technology programs: An association with autoimmune ovarian lesion |
|
| No 9 (2017) |
Articles |
Association of antibodies against gonadotropins and female sex hormones with reproductive disorders |
|
| No 1 (2018) |
Articles |
PATHOPHYSIOLOGICAL MECHANISMS OF OBSTETRIC ANTIPHOSPHOLIPID SYNDROME |
|
| No 2 (2019) |
Articles |
Antiphospholipid antibodies as diagnostic markers for obstetric antiphospholipid syndrome |
|
| No 7 (2020) |
Articles |
The clinical diagnostic value of maternal autoantibodies against extractable nuclear antigens in fetal bradyarrhythmia |
|
| No 8 (2020) |
Articles |
Antiphospholipid antibody profile, immunochemical properties, and diagnostic value in women with early recurrent spontaneous miscarriage |
|
| No 3 (2021) |
Articles |
Predictive value of autoimmune markers in assisted reproductive technologies |
|
| No 7 (2021) |
Articles |
Gam-COVID-Vac (Sputnik V) vaccine has no adverse effect on ovarian reserve in reproductive-age women |
|
| No 7 (2021) |
Articles |
Gam-COVID-Vac (Sputnik V) vaccine has no adverse effect on spermatogenesis in men |
|
| No 8 (2021) |
Articles |
Autoantibodies as risk factors for threatened miscarriage in women with early pregnancy loss |
|
| No 10 (2022) |
Articles |
The impact of COVID-19 on the outcomes of assisted reproductive technology programs |
|
| No 3 (2022) |
Articles |
Prevalence and importance of autoantibodies for non-invasive diagnostics of external genital endometriosis in women |
|
| No 2 (2023) |
Original Articles |
Antibodies to angiotensin-converting enzyme 2 in infertile patients with a history of COVID-19 and in fertile women |
|
| No 8 (2023) |
Original Articles |
Comparison of the profile of serum autoantibodies in women with different forms of endometriosis |
|
| No 11 (2024) |
Original Articles |
A profile of autoantibodies to steroid hormones and steroidogenic enzymes in women with endometriosis |
|
| No 12 (2024) |
Original Articles |
Features of the profile of serum autoantibodies to reproductive hormones and steroidogenic enzymes in patients with endometriosis-related infertility and infertile patients without endometriosis |
|
